Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesTelmisartan did not prevent recurrent stroke or major cardiovascular events
Evidence-Based Medicine, 06/10/09
Yusuf S - Groups did not differ for recurrent stroke, major cardiovascular events, or new-onset diabetes. In patients with ischaemic stroke, telmisartan did not prevent recurrent stroke, major cardiovascular events, or new-onset diabetes more than placebo.
Related Articles
Role of angiotensin receptor blockers in diabetes: implications of recent clinical trials
Expert Review of Cardiovascular Therapy, 11/16/09
Relevance Score: 85%
Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy
Hypertension Research, 11/09/09
Relevance Score: 80%
FDA approves Twynsta a new single pill combination that delivers powerful and consistent blood pressure reductions throughout 24 hours
Boehringer Ingelheim, 10/20/09
Relevance Score: 80%
Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors
Expert Review of Neurotherapeutics, 10/06/09
Relevance Score: 80%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia
Current Medical Research and Opinion, 12/18/09
Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study
Age and Aging, 12/18/09
Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
Lipids in Health and Disease, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor